scholarly article | Q13442814 |
P50 | author | Karen L Mossman | Q87062429 |
Martin R Stampfli | Q56426986 | ||
P2093 | author name string | Earl G Brown | |
Carla M T Bauer | |||
John D Taylor | |||
Fernando M Botelho | |||
Caleb C J Zavitz | |||
Kristen N Lambert | |||
P2860 | cites work | Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages | Q81301795 |
Innate immune processes are sufficient for driving cigarette smoke-induced inflammation in mice | Q84013691 | ||
Animal Models of Cigarette Smoke-Induced COPD* | Q22306060 | ||
Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus | Q28589623 | ||
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | Q29614960 | ||
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. | Q30375496 | ||
Toward a consensus definition for COPD exacerbations | Q33937749 | ||
Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). | Q36292150 | ||
Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations | Q36305342 | ||
Modelling COPD in mice. | Q36312380 | ||
Acetylcholine-induced calcium signaling and contraction of airway smooth muscle cells in lung slices | Q36445078 | ||
The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease | Q36601766 | ||
Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice | Q36789890 | ||
Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. | Q36791049 | ||
Global burden of COPD: risk factors, prevalence, and future trends | Q36926621 | ||
COPD exacerbations: defining their cause and prevention | Q36926629 | ||
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment | Q37017233 | ||
Immunology of asthma and chronic obstructive pulmonary disease | Q37084506 | ||
How cigarette smoke skews immune responses to promote infection, lung disease and cancer | Q37426272 | ||
Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease | Q37447470 | ||
The 2007 GOLD Guidelines: a comprehensive care framework. | Q37570645 | ||
New drugs for exacerbations of chronic obstructive pulmonary disease | Q37589154 | ||
Pioglitazone: side effect and safety profile | Q37696508 | ||
Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropium | Q37724621 | ||
Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. | Q40101329 | ||
CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality | Q44752156 | ||
Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile | Q44927752 | ||
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats | Q44989032 | ||
Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice | Q45006106 | ||
PPAR-gamma agonists as therapy for diseases involving airway neutrophilia | Q45006883 | ||
Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination | Q45411250 | ||
Influenza virus host response of C57Bl/6 mice treated with TACI-Ig | Q45416917 | ||
Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPAR gamma agonist in LPS-exposed guinea pigs. | Q46203001 | ||
Peroxisome proliferator-activated receptors as novel targets in lung disease | Q46483180 | ||
Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection | Q47939820 | ||
Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study | Q47970766 | ||
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations | Q58877199 | ||
Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease | Q77324413 | ||
Cigarette smoke impacts immune inflammatory responses to influenza in mice | Q79195225 | ||
Kinetics of in vitro bronchoconstriction in an elastolytic mouse model of emphysema | Q80405269 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
P304 | page(s) | e13251 | |
P577 | publication date | 2010-10-12 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection | |
P478 | volume | 5 |
Q30355446 | Adjunctive therapies and immunomodulating agents for severe influenza. |
Q30429289 | Adjunctive therapies and immunomodulatory agents in the management of severe influenza |
Q94571389 | An Update on Current Therapeutic Drugs Treating COVID-19 |
Q57097245 | Animal models of chronic obstructive pulmonary disease |
Q36579569 | Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice |
Q42251246 | Carbocisteine reduces virus-induced pulmonary inflammation in mice exposed to cigarette smoke |
Q34634788 | Continuous and discontinuous cigarette smoke exposure differentially affects protective Th1 immunity against pulmonary tuberculosis. |
Q42260374 | Development of a mouse model mimicking key aspects of a viral asthma exacerbation |
Q34894660 | How to approach and treat viral infections in ICU patients |
Q27311393 | IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice |
Q38977628 | Immune-mediated inflammation in the pathogenesis of emphysema: insights from mouse models |
Q30423093 | Immunopathogenesis of 2009 pandemic influenza |
Q59354505 | Impact of Cigarette Smoke Exposure on the Lung Fibroblastic Response after Influenza Pneumonia |
Q35129269 | Impact of cigarette smoke on the human and mouse lungs: a gene-expression comparison study |
Q37057787 | Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses |
Q37583861 | Influenza A virus infection and cigarette smoke impair bronchodilator responsiveness to β-adrenoceptor agonists in mouse lung |
Q30358340 | Influenza virus-induced lung inflammation was modulated by cigarette smoke exposure in mice. |
Q27023723 | Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments |
Q38181583 | Lipid-lowering drug therapies and chronic obstructive pulmonary disease: lung failure or just heart failure? |
Q34470424 | Modeling Pulmonary Disease Pathways Using Recombinant Adeno-Associated Virus 6.2. |
Q47648337 | Modeling tuberculosis pathogenesis through ex vivo lung tissue infection. |
Q41196865 | Mouse lung slices: An ex vivo model for the evaluation of antiviral and anti-inflammatory agents against influenza viruses |
Q35903449 | NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease |
Q38131512 | New anti-inflammatory targets for chronic obstructive pulmonary disease. |
Q38756064 | Novel approaches to the management of noneosinophilic asthma |
Q92494978 | Peroxisome Proliferator-Activated Receptor Gamma (PPAR) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection |
Q28660263 | Persistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposure |
Q91782536 | Ponatinib Protects Mice From Lethal Influenza Infection by Suppressing Cytokine Storm |
Q37426720 | Recent advances in pre-clinical mouse models of COPD. |
Q41682794 | Repeated lipopolysaccharide exposure causes corticosteroid insensitive airway inflammation via activation of phosphoinositide-3-kinase δ pathway |
Q27317947 | Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice |
Q35104537 | Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist |
Q47132665 | Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice |
Q35185316 | Targeting IL-1β and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation |
Q38694783 | The activation of NLRP3-inflammsome by stimulation of diesel exhaust particles in lung tissues from emphysema model and RAW 264.7 cell line |
Q30426929 | The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat |
Q38201056 | The influence of virus infections on the course of COPD. |
Q47554935 | The role of adjuvant immunomodulatory agents for treatment of severe influenza |
Q28535004 | Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation |
Q38261287 | Translational models of lung disease |
Q92030137 | Use of precision cut lung slices as a translational model for the study of lung biology |